Health Economics
|
|
Economic Analysis of Targeting Chemotherapy Using a 21-Gene RT-PCR Assay in Lymph Node-Negative, Estrogen Receptor-Positive, Early-Stage Breast Cancer
|
|
J Hornberger, LE Cosler, GH Lyman
|
|
Am J Manag Care
2005.11(5):313-324.
|
|
|
|
Impact of a 21-Gene RT-PCR Assay on Treatment Decisions in Early-Stage Breast Cancer, An Economic Analysis Based on Prognostic and Predictive Validation Studies
|
|
GH Lyman, LE Cosler, NM Kuderer, J Hornberger
|
|
Cancer
2007.109(6):1011-1018.
|
|
|
|
Does Oncotype DX recurrence score affect the management of patients with early-stage breast cancer?
|
|
Juhi Asad, D.O.a,b, Allyson F. Jacobson, M.D.a,b, Alison Estabrook, M.D.a,
Sharon Rosenbaum Smith, M.D.a, Susan K. Boolbol, M.D.b,
Sheldon M. Feldman, M.D.b, Michael P. Osborne, M.D.b,
Kwadwo Boachie-Adjei, M.Ph.c, Wendy Twardzik, R.P.A.-C.a, Paul I. Tartter, M.D.a,*
|
|
Am J Manag Care
2008.2008:.
|
|
|
|
Roadmap for Developing and Validating Therapeutically Relevant Genomic Classifiers
|
|
R Simon
|
|
J Clin Oncol
2005.23(29):7332-7341.
|
|
|
|
21-Gene RT-PCR Assay in Lymph Node-Negative (LN-), Estrogen Receptor-Positive (ER+) Breast Cancer: An Economic Analysis Including Prognostic and Predictive Information
|
|
LE Cosler, NM Kuderer, J Hornberger, GH Lyman
|
|
Abstract #6024: Poster Discussion
|
|
|
|
A 21-Gene RT-PCR Assay in Lymph Node-Negative (LN-), Estrogen Receptor-Positive (ER+) Early-Stage Breast Cancer (ESBC): An Age-Specific Economic Analysis
|
|
GH Lyman, L Cosler, J Hornberger
|
|
Abstract #2081: Poster Discussion
|
|
|
|
Economic Analysis of Targeting Chemotherapy (CT) Using a 21-Gene RT-PCR Assay in Lymph Node-Negative (LN-), Estrogen Receptor-Positive (ER+) Early-Stage Breast Cancer (ESBC)
|
|
LE Cosler, J Hornberger, GH Lyman
|
|
Abstract #6036: Poster Session
|
|
|
|
Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy
|
|
FJ Esteva, AA Sahin, M Cristofanilli, K Coombes, SJ Lee, J Baker, M Cronin, MG Walker, D Watson, S Shak, GN Hortobagyi
|
|
Abstract #17: Oral Presentation
|
|
|
|
Quantitative Gene Expression in Non-Small Cell Lung Cancer from Paraffin-Embedded Tissue Specimens: Predicting Response to Gefitinib, an EGFR Kinase Inhibitor
|
|
RB Natale, S Shak, N Aronson, S Averbuch, W Fox, D Luthringer, K Clark, J Baker, M Cronin, DB Agus
|
|
Abstract #763: Oral Presentation
|
|
|